Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Dermatologic 1

Conditions

Skin Neoplasms 3Carcinoma, Basal Cell 3Dermatofibrosarcoma 2Surgical Wound 1Nonmelanoma Skin Cancer 1Neoplasms, Adnexal and Skin Appendage 1Melanoma 1Histiocytoma, Malignant Fibrous 1Cicatrix 1Carcinoma, Squamous Cell 1

Interventions

Imatinib Mesylate 6Doxorubicin 4Mohs Surgery 2saracatinib 1ribociclib 1indolepropanol phosphate 1cixutumumab 1avelumab 1Watchful Waiting 1Sunitinib 1Razoxane 1Radiotherapy, Conformal 1Observation 1MLN 8237 1Immune Checkpoint Inhibitors 1Ifosfamide 1HhAntag691 1Dexrazoxane 1Cyclophosphamide 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Dermatofibrosarcoma × Mohs Surgery × Clear all
NCT03381846 2020-08-05

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Mayo Clinic

Phase NA Completed
7 enrolled
Sarcoma

Dermatofibrosarcoma

NCT02310503 2020-05-05

REGESMOHS

Fundación Academia Española de Dermatología

Completed
6,000 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Dermatofibrosarcoma, Neoplasms, Adnexal and Skin Appendage, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡